Participating in a clinical trial starts with finding a study that matches your condition, confirming you meet the eligibility requirements, and going through a formal enrollment process. The largest public database of trials is ClinicalTrials.gov, which lists over 400,000 studies worldwide, and most can be filtered by condition, location, and whether they’re actively recruiting. The process is more straightforward than many people expect, but understanding how trials work before you sign up helps you ask better questions and feel confident in your decision.
How to Find a Trial
ClinicalTrials.gov is the best starting point. On the search page, type your condition or disease into the basic search filter, then add your location (city, state, or zip code) to find studies near you. The most important filter to set is study status: select “Recruiting or not yet recruiting studies” so you only see trials that are actually looking for participants. From there, you can narrow results further by age group, treatment type, or trial phase using the “More Filters” menu on the left side of the results page.
Beyond the government database, many hospitals and academic medical centers maintain their own trial-matching services. Cancer centers in particular often have patient navigators who can identify relevant studies. Your own doctor or specialist can also refer you directly to a trial they know about or help you interpret listings you’ve found on your own. Some trials now include decentralized elements, meaning certain activities like telehealth visits, at-home check-ins with remote staff, or visits to a local provider can replace trips to a central research site. This makes participation possible even if the sponsoring institution is far from where you live.
What Eligibility Looks Like
Every trial has two lists that determine who can join: inclusion criteria and exclusion criteria. Inclusion criteria describe the target population the researchers need. These typically cover demographics like age and sex, clinical characteristics like a specific diagnosis or disease stage, and sometimes geographic location. A lung disease study, for example, might require participants to be over 40, have a confirmed diagnosis, and be a current or former smoker.
Exclusion criteria filter out people who technically fit the inclusion requirements but have additional characteristics that could complicate the results or put them at higher risk. Common reasons for exclusion include other medical conditions that might interfere with the treatment being tested, a high likelihood of missing scheduled appointments, or use of certain medications that could interact with the study drug. These criteria exist to protect you and to ensure the study produces reliable data. You won’t always know from the listing alone whether you qualify, so contacting the study team directly is a normal and expected step.
Understanding Trial Phases
Clinical trials progress through four phases, and the phase tells you a lot about what participation involves.
- Phase 1 enrolls 20 to 100 people and focuses on safety and dosage. These studies determine whether a treatment is safe enough to test further. Participants may be healthy volunteers or people with the condition being studied.
- Phase 2 enrolls up to several hundred people who have the disease or condition. The goal shifts to whether the treatment actually works and what side effects emerge. These studies typically last several months to two years.
- Phase 3 enrolls 300 to 3,000 participants and runs one to four years. This is where researchers confirm effectiveness, monitor for less common adverse reactions, and compare the new treatment to existing standard care.
- Phase 4 happens after a treatment has already been approved. These studies track safety and effectiveness in several thousand people over longer periods of real-world use.
Earlier-phase trials carry more uncertainty because less is known about the treatment. Later-phase trials offer more data on what to expect but may involve randomization, meaning you could be assigned to the new treatment or to a comparison group receiving standard care or a placebo.
The Informed Consent Process
Before you officially enroll, the research team walks you through informed consent. This is not just a form to sign. It’s a conversation, and the team is legally required to explain specific things: that the study is research, what its purpose is, how long your participation will last, exactly which procedures are experimental, any foreseeable risks or discomforts, potential benefits to you or others, and what alternative treatments exist outside the trial.
They must also tell you how your medical records and personal information will be kept confidential, whether compensation or medical treatment is available if you’re injured during the study, and who to contact with questions at any point. Critically, the consent document must state that participation is voluntary, that refusing to join carries no penalty, and that you can leave at any time without losing access to any benefits or care you’re otherwise entitled to. Take the consent document home if you need time. You are never expected to decide on the spot.
How Your Safety Is Protected
Every clinical trial involving human participants must be reviewed and approved by an Institutional Review Board (IRB) before it begins. An IRB is an independent committee with the authority to approve, require changes to, or reject a research study. Its job is to ensure the study design adequately protects participants’ rights and welfare. The board reviews the research protocol, the informed consent documents, and any materials given to participants.
The IRB’s oversight doesn’t end once a trial starts. Any changes to the study protocol must receive IRB approval before being implemented, unless an immediate change is needed to protect participants from harm. If the study is modified in a way that might affect your willingness to continue, you must be informed. The IRB also has the authority to observe the consent process or audit the study’s conduct if concerns arise.
Costs, Compensation, and Insurance
One of the most common concerns about joining a trial is cost. In many studies, the experimental treatment itself is provided at no charge by the sponsor. Routine care costs, like doctor visits and lab tests you’d need regardless of the trial, often remain your responsibility or your insurance company’s. The exact split varies by study, so this is something to clarify before enrolling.
Many trials compensate participants for their time and inconvenience. The FDA considers this a recruitment incentive, not a benefit that factors into the risk assessment. Compensation typically accrues as the study progresses rather than being paid as a lump sum at the end, so you’re not financially penalized for leaving early. A small bonus for completing the full study is allowed as long as it’s not large enough to pressure someone into staying. Reimbursement for travel expenses like parking, gas, airfare, and lodging is handled separately and is standard in many trials. Before you enroll, ask the study coordinator exactly which costs you’ll be responsible for and what your insurance will cover.
Questions Worth Asking Before You Enroll
The National Cancer Institute recommends a set of questions that applies well beyond cancer trials. Before joining any study, consider asking:
- About the trial itself: What is the purpose? Why do researchers think this treatment may be better than what’s currently available? How long will I be in the study, and how many visits are required? How will the doctor know if the treatment is working?
- About risks and benefits: What are the possible side effects? How do the risks compare to standard treatment? What happens if the treatment doesn’t work for me?
- About daily life: How will this affect my routine? Will I need to stay in the hospital at any point? How far will I need to travel, and how often?
- About costs: Which expenses will I need to pay? What will insurance cover? Is there someone on the study team who can help with insurance questions?
- About what comes after: Will I have follow-up check-ups? How and when will I learn the trial’s results?
You can also ask who will be in charge of your care during the trial and whether you’ll still see your regular doctor. Having clear answers to these questions before you commit makes the entire experience less stressful.
Your Right to Leave at Any Time
Federal regulations guarantee that you can withdraw from a clinical trial at any time, for any reason, without penalty or loss of benefits. This right is absolute. If you decide to leave, the research team must stop all study-related interventions, stop collecting new data about you, and stop accessing your private medical information for the study. If your withdrawal is limited to just the main treatment component, other parts of the study you previously agreed to (like follow-up surveys) may continue unless you say otherwise.
The informed consent process should also explain any circumstances under which the research team might end your participation without your consent, such as safety concerns or changes in your health. If that happens, the team must explain the consequences and help you transition back to standard care in an orderly way. Leaving a trial does not affect your right to receive medical treatment outside the study.